52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Cardinal Health Files For Potential Mixed Shelf Offering, Size Not Disclosed
Cardinal Health, On Opioid Lawsuits, Says Defense & Resolution Of Lawsuits Could Have A Material Adverse Effect On Results Of Operations
Cardinal Health Inc Says On August 7, Appointed David Evans As Interim Chief Financial Officer Of Company, Effective September 1, 2019
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Biotechnology & Drugs
7000 Cardinal Pl
Gregory B. Kenny
Non-Executive Chairman of the Board
Michael C. Kaufmann
Chief Executive Officer, Director
David C. Evans
Interim Chief Financial Officer
Stephen M Mason
Chief Executive Officer-Medical Segment
Pamela O. Kimmet
Chief Human Resource Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Drug distributor Cardinal Health Inc warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits.
Drug distributor Cardinal Health Inc warned on Tuesday that its business could take a hit as it defends itself against a host of opioid-related lawsuits.
Drug wholesalers AmerisourceBergen Corp <ABC.N>, McKesson Corp <MCK.N> and Cardinal Health Inc <CAH.N> have proposed a $10 billion settlement for claims that they played a part in the U.S. opioid epidemic, Bloomberg reported on Tuesday, citing people familiar with negotiations...
U.S. drug distributor Cardinal Health Inc beat analyst estimates for adjusted fourth-quarter profit on Monday, supported by higher sales in its pharmaceutical and medical devices businesses.
Cardinal Health Inc reported a fourth-quarter loss compared to a year-ago profit, as the U.S. drug distributor was hit by an asset-impairment charge of $1.35 billion.
Cardinal Health Inc's <CAH.N> quarterly profit missed analysts' expectations as inventory and cost issues hurt its Cordis medical device unit, and the U.S. drug distributor said it saw prices of generic drugs fall more than expected.
U.S. drug distributor Cardinal Health Inc posted a 33 percent fall in quarterly profit on Thursday, hurt by a change in the company's effective tax rate primarily associated with its Cordis business.
* CARDINAL HEALTH REPORTS THIRD-QUARTER RESULTS FOR FISCAL YEAR 2018
* CARDINAL HEALTH RECOMMENDS SHAREHOLDERS REJECT THE BELOW-MARKET MINI-TENDER OFFER BY TRC CAPITAL CORPORATION
Kentucky's attorney general on Monday filed a lawsuit against drug distributor Cardinal Health Inc , accusing it of contributing to the opioid epidemic by failing to halt or report suspiciously large or frequent orders by pharmacies of prescription painkillers.
Kentucky's attorney general on Monday accused the drug distributor Cardinal Health Inc of contributing to the opioid epidemic by failing to halt or report suspiciously large or frequent orders by pharmacies of prescription painkillers.
* BARROW, HANLEY, MEWHINNEY & STRAUSS, LLC REPORTS 5.68 PERCENT PASSIVE STAKE IN CARDINAL HEALTH INC AS OF DECEMBER 31, 2017 - SEC FILING Source text (http://bit.ly/2CfIHSC) Further company coverage:
Cardinal Health's <CAH.N> quarterly profit topped analysts' estimates as the U.S. drug distributor benefited from its purchase of Medtronic Plc's <MDT.N> patient care business and a tie-up with drugstore chain CVS Health Corp <CVS.N>.
* CARDINAL HEALTH REPORTS SECOND-QUARTER RESULTS FOR FISCAL YEAR 2018
Cardinal Health said on Thursday its quarterly profit more than tripled due to a benefit related to recent changes in U.S. tax laws.
* CARDINAL HEALTH INC - WITH JOHRI'S ADDITION, BOARD WILL CONSIST OF THIRTEEN DIRECTORS Source text for Eikon: Further company coverage:
* CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM Source text for Eikon: Further company coverage:
* Cardinal Health put business up for sale due to rule changes
State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China business, one of the nation's largest drug distributors, for $557 million.
* Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.